omeprazole has been researched along with Bone Diseases, Metabolic in 3 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The body weight gain was suppressed by omeprazole treatment." | 7.71 | Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. ( Chen, D; Cui, GL; Syversen, U; Waldum, HL; Zhao, CM, 2001) |
| "The body weight gain was suppressed by omeprazole treatment." | 3.71 | Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. ( Chen, D; Cui, GL; Syversen, U; Waldum, HL; Zhao, CM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pytlik, M | 1 |
| Cegieła, U | 1 |
| Folwarczna, J | 1 |
| Nowińska, B | 1 |
| Gepp, H | 1 |
| Koch, M | 1 |
| Schwille, PO | 1 |
| Erben, RG | 1 |
| Rümenapf, G | 1 |
| Schmiedl, A | 1 |
| Fries, W | 1 |
| Cui, GL | 1 |
| Syversen, U | 1 |
| Zhao, CM | 1 |
| Chen, D | 1 |
| Waldum, HL | 1 |
3 other studies available for omeprazole and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alendronate; Animals; Bone and Bones; Bone Density; Bone De | 2012 |
Vagus-sparing gastric fundectomy in the rat: development of osteopenia, relationship to urinary phosphate and net acid excretion, serum gastrin and vitamin D.
Topics: Acid-Base Equilibrium; Animals; Autonomic Nervous System; Bone Density; Bone Diseases, Metabolic; Ga | 2000 |
Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats.
Topics: Age Factors; Animals; Anti-Ulcer Agents; Bone Diseases, Metabolic; Calcification, Physiologic; Enter | 2001 |